In this webinar we will:
- ● identify the genes that impact the metabolism and activity of opioid and non-opioid analgesics
- ● discuss how pharmacogenomic variants can affect the safety of pain management medications
- ● evaluate clinical studies investigating pharmacogenomic testing in treating postoperative pain, cancer-related pain, and pain in pediatrics
About the presenter
Ryan Gregg, Ph.D. is the Medical Science Liaison for the NE and SE U.S. at OneOme. He obtained a B.S. with Honors in Forensic Chemistry from the University of Mississippi, and a Ph.D. in Pharmacology from the Center for Substance Abuse and Research at Temple University School of Medicine. Ryan's background includes pre-clinical opioid analgesic research, which first sparked his interest in understanding all of the mechanisms underlying the different responses to pain medication.